دورية أكاديمية

Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults.

التفاصيل البيبلوغرافية
العنوان: Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults.
المؤلفون: Khan AA; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada. aliya@mcmaster.ca., Brandi ML; F.I.R.M.O. Italian Foundation for the Research On Bone Diseases, Florence, Italy.; Donatello Bone Clinic, Villa Donatello Hospital, Florence, Italy., Rush ET; Division of Clinical Genetics, Children's Mercy Kansas City, Kansas City, MO, USA.; Division of Endocrinology, Metabolism, Osteoporosis and Genetics, Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA., Ali DS; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada., Al-Alwani H; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada., Almonaei K; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada., Alsarraf F; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada., Bacrot S; Department of Genetics, Centre Hospitalier de Versailles, Hôpital André Mignot, Versailles, France., Dahir KM; Division of Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA., Dandurand K; Department of Medicine, Endocrinology and Metabolism, Université de Sherbrooke, Sherbrooke, QC, Canada., Deal C; Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatology, The Cleveland Clinic Foundation, Cleveland, OH, USA., Ferrari SL; Division of Bone Diseases, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Giusti F; Donatello Bone Clinic, Villa Donatello Hospital, Florence, Italy., Guyatt G; Department of Health Research Methods, Evidence and Impact at McMaster University, Hamilton, Canada., Hatcher E; Neuromuscular Clinic, McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Canada., Ing SW; Division of Endocrinology, Diabetes & Metabolism, Ohio State University Wexner Medical Center, Columbus, OH, USA., Javaid MK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Khan S; Bone Research and Education Centre, Oakville, ON, Canada., Kocijan R; Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA, Trauma Centre Meidling, 1St Medical Department Hanusch Hospital, 1140, Vienna, Austria., Linglart A; APHP, Bicêtre Paris-Sud, UniversityParis Sud, Paris-Saclay, Le Kremlin Bicêtre, Paris, France., M'Hiri I; Bone Research and Education Centre, Oakville, ON, Canada., Marini F; F.I.R.M.O. Italian Foundation for the Research On Bone Diseases, Florence, Italy., Nunes ME; Division of Medical Genetics and Metabolism, Valley Children's HealthCare, Madera, CA, USA., Rockman-Greenberg C; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada., Roux C; INSERM CRESS UMR 1153, Paris, France.; Université Paris-Cité, Department of Rheumatology, APHP-Centre, Cochin Hospital, Paris, France., Seefried L; Musculoskeletal Center Wuerzburg, University of Würzburg, Würzburg, Germany., Simmons JH; Division of Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA., Starling SR; Division of Clinical Genetics, Children's Mercy Kansas City, Kansas City, MO, USA., Ward LM; Children's Hospital of Eastern Ontario, Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada., Yao L; Department of Health Research Methods, Evidence and Impact at McMaster University, Hamilton, Canada., Brignardello-Petersen R; Department of Health Research Methods, Evidence and Impact at McMaster University, Hamilton, Canada., Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
المصدر: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2024 Mar; Vol. 35 (3), pp. 431-438. Date of Electronic Publication: 2023 Nov 20.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2965 (Electronic) Linking ISSN: 0937941X NLM ISO Abbreviation: Osteoporos Int Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London, UK : Springer International, c1990-
مواضيع طبية MeSH: Hypophosphatasia*/diagnosis , Hypophosphatasia*/genetics, Adult ; Child ; Humans ; Mutation ; Retrospective Studies ; Alkaline Phosphatase/genetics ; Genotype ; Phenotype
مستخلص: Background: This manuscript provides a summary of the current evidence to support the criteria for diagnosing a child or adult with hypophosphatasia (HPP). The diagnosis of HPP is made on the basis of integrating clinical features, laboratory profile, radiographic features of the condition, and DNA analysis identifying the presence of a pathogenic variant of the tissue nonspecific alkaline phosphatase gene (ALPL). Often, the diagnosis of HPP is significantly delayed in both adults and children, and updated diagnostic criteria are required to keep pace with our evolving understanding regarding the relationship between ALPL genotype and associated HPP clinical features.
Methods: An International Working Group (IWG) on HPP was formed, comprised of a multidisciplinary team of experts from Europe and North America with expertise in the diagnosis and management of patients with HPP. Methodologists (Romina Brignardello-Petersen and Gordon Guyatt) and their team supported the IWG and conducted systematic reviews following the GRADE methodology, and this provided the basis for the recommendations.
Results: The IWG completed systematic reviews of the literature, including case reports and expert opinion papers describing the phenotype of patients with HPP. The published data are largely retrospective and include a relatively small number of patients with this rare condition. It is anticipated that further knowledge will lead to improvement in the quality of genotype-phenotype reporting in this condition.
Conclusion: Following consensus meetings, agreement was reached regarding the major and minor criteria that can assist in establishing a clinical diagnosis of HPP in adults and children.
(© 2023. Crown.)
التعليقات: Erratum in: Osteoporos Int. 2024 Mar 18;:. (PMID: 38498158)
References: Khan AA et al (2019) Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int 30(9):1713–1722. (PMID: 3091550710.1007/s00198-019-04921-y)
Bianchi ML et al (2020) Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int 31(8):1445–1460. (PMID: 3216201410.1007/s00198-020-05345-9)
Whyte MP (2016) Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233–246. (PMID: 2689326010.1038/nrendo.2016.14)
Rockman-Greenberg C (2013) Hypophosphatasia. Pediatr Endocrinol Rev 10(Suppl 2):380–388. (PMID: 23858621)
Seefried L et al (2020) Burden of illness in adults with hypophosphatasia: data from the Global Hypophosphatasia Patient Registry. J Bone Miner Res 35(11):2171–2178. (PMID: 3265418310.1002/jbmr.4130)
Whyte MP (2009) Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res 24(6):1132–1134. (PMID: 1911392310.1359/jbmr.081253)
Bishop N (2015) Clinical management of hypophosphatasia. Clin Cases Mineral Bone Metab : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 12(2):170–173.
Jemmerson R, Low MG (1987) Phosphatidylinositol anchor of HeLa cell alkaline phosphatase. Biochemistry 26(18):5703–5709. (PMID: 367627910.1021/bi00392a019)
Seetharam B, Tiruppathi C, Alpers DH (1987) Hydrophobic interactions of brush border alkaline phosphatases: the role of phosphatidyl inositol. Arch Biochem Biophys 253(1):189–198. (PMID: 381356210.1016/0003-9861(87)90651-5)
Le Du MH, Millan JL (2002) Structural evidence of functional divergence in human alkaline phosphatases. J Biol Chem 277(51):49808–49814. (PMID: 1237283110.1074/jbc.M207394200)
Orimo H (2010) The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch 77(1):4–12. (PMID: 2015445210.1272/jnms.77.4)
Fedde KN, Whyte MP (1990) Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5’-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study. Am J Hum Genet 47(5):767–775. (PMID: 22208171683690)
Fedde KN et al (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14(12):2015–2026. (PMID: 1062006010.1359/jbmr.1999.14.12.2015)
Lei W et al (2013) Alkaline phosphatases contribute to uterine receptivity, implantation, decidualization, and defense against bacterial endotoxin in hamsters. Reproduction 146(5):419–432. (PMID: 23929901380536910.1530/REP-13-0153)
Narisawa S, Yadav MC, Millán JL (2013) In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin. J Bone Miner Res 28(7):1587–1598. (PMID: 2342708810.1002/jbmr.1901)
Millán JL (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 93(4):299–306. (PMID: 2318378610.1007/s00223-012-9672-8)
Fleisch H, Russell RG, Straumann F (1966) Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212(5065):901–903. (PMID: 430679310.1038/212901a0)
Sutton RA et al (2012) “Atypical femoral fractures” during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 27(5):987–994. (PMID: 2232254110.1002/jbmr.1565)
Bhattacharyya T et al (2016) Hypophosphatasia and the risk of atypical femur fractures: a case-control study. BMC Musculoskelet Disord 17:332. (PMID: 27507156497789610.1186/s12891-016-1191-8)
Wong YW, Low MG (1994) Biosynthesis of glycosylphosphatidylinositol-anchored human placental alkaline phosphatase: evidence for a phospholipase C-sensitive precursor and its post-attachment conversion into a phospholipase C-resistant form. Biochemical journal 301(1):205–209. (PMID: 8037672113716310.1042/bj3010205)
Nosjean O et al (1997) Human tissue non-specific alkaline phosphatases: sugar-moiety-induced enzymic and antigenic modulations and genetic aspects. Biochemical journal 321(2):297–303. (PMID: 9020858121806810.1042/bj3210297)
Colazo JM et al (2019) Neurological symptoms in hypophosphatasia. Osteoporos Int 30(2):469–480. (PMID: 3021511610.1007/s00198-018-4691-6)
Hofmann C et al (2013) Compound heterozygosity of two functional null mutations in the ALPL gene associated with deleterious neurological outcome in an infant with hypophosphatasia. Bone 55(1):150–157. (PMID: 2345448810.1016/j.bone.2013.02.017)
Sato M et al (2021) Tissue-nonspecific alkaline phosphatase, a possible mediator of cell maturation: towards a new paradigm. Cells 10(12):3338. (PMID: 34943845869912710.3390/cells10123338)
Whyte MP et al (2015) Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone 75:229–239. (PMID: 2573196010.1016/j.bone.2015.02.022)
Bowen RA et al (2010) Impact of blood collection devices on clinical chemistry assays. Clin Biochem 43(1–2):4–25. (PMID: 1982213910.1016/j.clinbiochem.2009.10.001)
Mohri M, Rezapoor H (2009) Effects of heparin, citrate, and EDTA on plasma biochemistry of sheep: comparison with serum. Res Vet Sci 86(1):111–114. (PMID: 1857220910.1016/j.rvsc.2008.05.010)
Eastell R et al (2011) Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res 26(3):530–537. (PMID: 2083929010.1002/jbmr.251)
Kruse K et al (1989) Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment. Eur J Pediatr 148(6):535–539. (PMID: 274401510.1007/BF00441552)
Clarke BL (2014) Bone disease in hypoparathyroidism. Arq Bras Endocrinol Metabol 58(5):545–552. (PMID: 2516604610.1590/0004-2730000003399)
Lum G (1995) Significance of low serum alkaline phosphatase activity in a predominantly adult male population. Clin Chem 41(4):515–518. (PMID: 772023910.1093/clinchem/41.4.515)
Osella G et al (1997) Serum markers of bone and collagen turnover in patients with Cushing’s syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 82(10):3303–3307. (PMID: 9329358)
Bardin T (1992) Renal osteodystrophy, disorders of vitamin D metabolism, and hypophosphatasia. Curr Opin Rheumatol 4(3):389–393. (PMID: 159982010.1097/00002281-199206000-00018)
Siddique A, Kowdley KV (2012) Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis 16(2):199–229. (PMID: 22541695334163310.1016/j.cld.2012.03.012)
Lund T et al (2010) Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis*. Eur J Haematol 84(5):412–420. (PMID: 20070853287117110.1111/j.1600-0609.2010.01417.x)
Shaver WA, Bhatt H, Combes B (1986) Low serum alkaline phosphatase activity in Wilson’s disease. Hepatology 6(5):859–863. (PMID: 375894010.1002/hep.1840060509)
Korman JD et al (2008) Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 48(4):1167–1174. (PMID: 1879833610.1002/hep.22446)
Yücel D, Dalva K (1992) Effect of in vitro hemolysis on 25 common biochemical tests. Clin Chem 38(4):575–577. (PMID: 156832510.1093/clinchem/38.4.575)
Shapiro JR, Lewiecki EM (2017) Hypophosphatasia in adults: clinical assessment and treatment considerations. J Bone Miner Res 32(10):1977–1980. (PMID: 2873121510.1002/jbmr.3226)
Linglart A, Salles JP (2017) Hypophosphatasia: the contribution of imaging. Arch Pediatr 24(5S2):5S74-5S79. (PMID: 2940593710.1016/S0929-693X(18)30019-8)
Mannes I et al (2022) Imaging patterns in pediatric hypophosphatasia. Pediatr Radiol 52(5):998–1006. (PMID: 3485496610.1007/s00247-021-05232-3)
Mornet E (2017) Genetics of hypophosphatasia. Arch Pediatr 24(5):5S51-5S56. (PMID: 2940593210.1016/S0929-693X(18)30014-9)
Taillandier A et al (2015) Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted Next Generation Sequencing. Mol Genet Metab 116(3):215–220. (PMID: 26432670525727810.1016/j.ymgme.2015.09.010)
Payne RB (1998) Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation. Annal Clin Biochem: international journal of laboratory medicine 35(2):201–206. (PMID: 10.1177/000456329803500203)
Shaker JL et al (2015) Recent developments in osteogenesis imperfecta. F1000Res 4(F1000 Faculty Rev):681. (PMID: 26401268456628310.12688/f1000research.6398.1)
Shapiro JR, Brennen F-S (2014) Chapter 55 - Osteogenesis imperfecta: maintenance of adult bone health. In: Shapiro JR et al (eds) Osteogenesis imperfecta. Academic Press, San Diego, pp 509–518. (PMID: 10.1016/B978-0-12-397165-4.00055-1)
Mornet E (2007) Hypophosphatasia. Orphanet J Rare Dis 2(1):40. (PMID: 17916236216494110.1186/1750-1172-2-40)
Mohn A et al (2011) Hypophosphatasia in a child with widened anterior fontanelle: lessons learned from late diagnosis and incorrect treatment. Acta Paediatr 100(7):e43–e46. (PMID: 2134225110.1111/j.1651-2227.2011.02228.x)
Nield LS et al (2006) Rickets: not a disease of the past. Am Fam Physician 74(4):619–626. (PMID: 16939184)
Carpenter TO et al (2011) A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res 26(7):1381–1388. (PMID: 2153851110.1002/jbmr.340)
Reynolds RD et al (1991) Extremely low serum pyridoxal 5′-phosphate in children with familial hypophosphatemic rickets. Am J Clin Nutr 53(3):698–701. (PMID: 200082510.1093/ajcn/53.3.698)
Tournis ST et al (2005) Co-existence of X-linked hypophosphatemic rickets (XLH) and primary hyperparathyroidism: case report and review of the literature. J Musculoskelet Neuronal Interact 5(2):150–154. (PMID: 15951631)
Kramer K et al (2021) Dental defects in the primary dentition associated with hypophosphatasia from biallelic ALPL mutations. Bone 143:115732. (PMID: 3316009510.1016/j.bone.2020.115732)
فهرسة مساهمة: Keywords: Diagnosis; Hypophosphatasia; Major criteria; Minor criteria
المشرفين على المادة: EC 3.1.3.1 (Alkaline Phosphatase)
تواريخ الأحداث: Date Created: 20231120 Date Completed: 20240215 Latest Revision: 20240406
رمز التحديث: 20240406
مُعرف محوري في PubMed: PMC10866785
DOI: 10.1007/s00198-023-06844-1
PMID: 37982857
قاعدة البيانات: MEDLINE
الوصف
تدمد:1433-2965
DOI:10.1007/s00198-023-06844-1